Literature DB >> 12374450

Parenteral busulfan: is therapeutic monitoring still warranted?

Louise B Grochow1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12374450     DOI： 10.1053/bbmt.2002.v8.pm12374450

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  1 in total

1.  Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.

Authors:  Peter H O'Donnell; Andrew S Artz; Samir D Undevia; Rish K Pai; Paula Del Cerro; Sarah Horowitz; Lucy A Godley; John Hart; Federico Innocenti; Richard A Larson; Olatoyosi M Odenike; Wendy Stock; Koen Van Besien
Journal:  Leuk Lymphoma       Date:  2010-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.